Eyelines Opticians launches advanced retinal OCT scanning services to help detect wet and dry macular degeneration early. The ...

LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Light™ to offer a comprehensive approach for detecting, treating, and monitoring retinal diseases, specifically ...

Purpose: To develop and evaluate a deep learning system for screening multiple abnormal findings including hemorrhages, drusen, hard exudates, cotton wool spots and retinal breaks using ...

At ARVO 2025, in Salt Lake City, Utah, Danielle Gauthier talked about her poster on autosomal dominant Alzheimer disease in relation to optic nerve head drusen.

Aims To assess choriocapillaris flow deficit percentage (CCFD%) across stages of dry age-related macular degeneration (AMD) using swept-source optical coherence tomography angiography (SS-OCTA).

For the models, investigators resourced standard retinal features detected in 8848 participants of AREDS and AREDS2. The AMD-D model appraised several signs, including hard drusen size, soft drusen ...

Cognition Therapeutics updates on Alzheimer’s and DLB programs, FDA meeting request, and financial results for Q1 2025.

New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.

Differential diagnoses of AMD include other macular diseases with drusen, drusen-like changes, monogenic retinal dystrophies and rare macular diseases.

The retinal pigment epithelium (RPE) attenuates both incident and reflected light due to its scattering properties. In normal eyes and eyes with drusen, the compensation strategy described above is ...

In eyes with intermediate age-related macular degeneration (iAMD), the area of retinal pigment epithelium hyperreflective foci (rpeHRF) predicts disease progression to the onset of large persistent ...